JAGX (Jaguar Health, Inc.) Stock Analysis - Analyst Ratings

Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of May 20, 2026, JAGX trades at $3.77 with a market cap of $1.90M and a P/E ratio of -0.16. JAGX moved +0.00% today. Year to date, JAGX is -88.80%; over the trailing twelve months it is -98.02%. Its 52-week range spans $2.53 to $1,121.59. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate JAGX?

The average price target is $0.00.

JAGX Key Metrics

Key financial metrics for JAGX
MetricValue
Price$3.77
Market Cap$1.90M
P/E Ratio-0.16
EPS$-22.97
Dividend Yield0.00%
52-Week High$1,121.59
52-Week Low$2.53
Volume29.76K
Avg Volume0
Revenue (TTM)$11.51M
Net Income$-54.00M
Gross Margin67.21%

JAGX Analyst Consensus

JAGX analyst coverage data. Average price target: $0.00.

Latest JAGX News

Common questions about JAGX

What do analysts rate JAGX?
The average price target is $0.00.
Does Rallies show JAGX price targets?
Yes. Rallies tracks JAGX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is JAGX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JAGX. It does not provide personalized investment advice.
JAGX

JAGX